Keloid Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies - Novartis Pharmaceuticals, Aviva Pharma

(Las Vegas, Nevada, United States) DelveInsight's "Keloid Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Keloid, historical and forecasted epidemiology as well as the Keloid market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Download Sample Report to know more
https://www.delveinsight.com/sample-request/keloid-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Keloid Overview
Keloid, also known as keloid disorder and keloidal scar, is the formation of a type of scar which, depending on its maturity, is composed mainly of either type III (early) or type I (late) collagen. It is a result of an overgrowth of granulation tissue (collagen type 3) at the site of a healed skin injury which is then slowly replaced by collagen type 1. Keloids are firm, rubbery lesions or shiny, fibrous nodules, and can vary from pink to the color of the person's skin or red to dark brown in color. A keloid scar is benign and not contagious, but sometimes accompanied by severe itchiness, pain, and changes in texture. In severe cases, it can affect the movement of the skin.
Signs and symptoms of the disease include Thick, irregular scarring, typically on the earlobes, shoulders, cheeks, or middle chest. Shiny, hairless, lumpy, raised skin.
Varied size, depending on the size of the original injury and when the keloid stops growing.Varied texture, from soft to firm and rubbery.

Click here to learn more about the Keloid Market Landscape @https://www.delveinsight.com/report-store/keloid-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Key Highlight from Keloid Market Report
True incidence and prevalence of keloid in the United States is not known. Indeed, there has never been a population study to assess the epidemiology of this disorder. In his 2001 publication, Marneros[19] stated that the "reported incidence of keloids in the general population ranges from a high of 16% among the adults in the Democratic Republic of the Congo to a low of 0.09% in England," quoting from Bloom's 1956 publication on the heredity of keloids.[20] Clinical observations show that the disorder is more common among sub-Saharan Africans, African Americans and Asians, with unreliable and very wide estimated prevalence rates ranging from 4.5 to 16%

Keloid Treatment Market
Treatments (both preventive and therapeutic) available are pressure therapy, silicone gel sheeting, intra-lesional triamcinolone acetonide, cryosurgery (freezing), radiation, laser therapy (pulsed dye laser), interferon (IFN), fluorouracil (5-FU) and surgical excision as well as a multitude of extracts and topical agents. Appropriate treatment of a keloid scar is age-dependent: radiotherapy, anti-metabolites, and corticosteroids would not be recommended to be used in children, in order to avoid harmful side effects, like growth abnormalities.
In adults, corticosteroids combined with 5-FU and PDL in triple therapy, enhance results and diminish side effects

Learn more about the treatment market for Keloid @ https://www.delveinsight.com/report-store/keloid-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

The Report Covers the Keloid Epidemiology Segmented by
Keloid Prevalent cases
Keloid Incident Cases
Keloid treatment cases
Keloid Diagnosed cases
Keloid Dug Profile and Companies Covered
Novartis Pharmaceuticals
Aviva Biopharmaceuticals
MiRagen Therapeutics Inc
Rxi Pharmaceuticals
Oculus Innovation Inc
And many others.

Learn more about the Key Companies and Emerging Therapies in the Hemophilia Market @ https://www.delveinsight.com/report-store/keloid-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Table of Contents
Key Insights
Keloid Introduction
Executive Summary of Keloid
Disease Background and Overview
Keloid Epidemiology and patient population
Keloid Emerging Therapies
Keloid Market Outlook
Keloid Market Access and Reimbursement of Therapies
Keloid Market Drivers
Keloid Market Barriers
Appendix
Keloid Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Keloid Market Outlook report @ https://www.delveinsight.com/report-store/keloid-market utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Related Reports
Keloid Epidemiology Forecast
https://www.delveinsight.com/report-store/keloid-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.